Oct 6, 2026
Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs“MIT researchers have found that lung tumor cells can become resistant to KRAS inhibitors by undergoing a transformation from adenocarcinoma to squamous cell carcinoma.” Scientists just found...
Sep 22, 2026
Noninvasive imaging-based vascular score is associated with immunotherapy outcome in non-small cell lung cancer“Morphological abnormality in tumor vasculature, a recently recognized mechanism of resistance to immune checkpoint inhibitors (ICIs), remains difficult to...
Sep 15, 2026
Enhertu demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial“In the primary endpoint of PFS, Enhertu monotherapy significantly reduced the...
Sep 8, 2026
Inhaled Microplastics Linked To Lung Cancer, Study Finds“About 66% of lung cancer patients had detectable microplastics found in fluid samples taken from their lungs, compared to 46% of people without lung cancer, researchers reported Sunday at a meeting of the...
Aug 5, 2026
FDA Approves Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer “On July 22, the U.S. Food and Drug Administration (FDA) approved zidesamtinib (Jideytro) for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who were...
More News and Updates